Unknown

Dataset Information

0

The effects of the introduction of a chronic care model-based program on utilization of healthcare resources: the results of the Puglia care program.


ABSTRACT: Ageing is continuously increasing the prevalence of patients with chronic conditions, putting pressure on the sustainability of Healthcare Systems. Chronic Care Models (CCM) have been used to address the needs of frail people in the continuum of care, testifying to an improvement in health outcomes and more efficient access to healthcare services. The impact of CCM deployment has already been experienced in a selected cohort of patients affected by specific chronic illnesses. We have investigated its effects in a heterogeneous frail cohort included in a regional CCM-based program.a retrospective population-based cohort study was carried out involving a non-oncological cohort of adult subjects with chronic diseases included in the CCM-oriented program (Puglia Care). Individuals in usual care with comparable demographic and clinical characteristics were selected for matched pair analysis. Study cohorts were defined by using a record linkage analysis of administrative databases and electronic medical records, including data on the adult population in the 6 local area health authorities of Puglia in Italy (approximately 2 million people). The effects of Puglia Care on the utilizations of healthcare resources were evaluated both in a before-after and in a case-control analysis.There were 1074 subjects included in Puglia Care and 2126 matched controls. In before-after analysis of the Puglia Care cohort, 240 unplanned hospitalizations occurred in the pre-inclusion period, while 239 were registered during follow-up. The incidence of unplanned hospitalization was 10.3 per 100 person/year (95% CI, 9.1-11.7) during follow-up and 12.1 per 100 person/year (95% CI, 10.7-13.8) in the pre-inclusion period (IRR, 0.84; 95% CI, 0.80-0.99). During follow-up a significant reduction in costs related to unplanned hospitalizations (IRR, 0.92; 95% CI, 0.91-0.92) was registered, while costs related to drugs (IRR, 1.14; p 

SUBMITTER: Robusto F 

PROVIDER: S-EPMC5970509 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC6991264 | BioStudies
2018-01-01 | S-EPMC6645680 | BioStudies
2020-01-01 | S-EPMC7245390 | BioStudies
2015-01-01 | S-EPMC4484589 | BioStudies
2015-01-01 | S-EPMC4684806 | BioStudies
2007-01-01 | S-EPMC2219867 | BioStudies
2020-01-01 | S-EPMC7576407 | BioStudies
2019-01-01 | S-EPMC6492469 | BioStudies
2019-01-01 | S-EPMC6964390 | BioStudies
2018-01-01 | S-EPMC6230207 | BioStudies